Myocardial FDG Uptake Changes After Thoracic Radiotherapy With Cardiac Exposure
Clinical Nuclear Medicine Open · 2026-06 · 3 (2)
DOI: 10.1097/nm9.0000000000000083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nuclear Medicine Open, 2026-06. Verfasst von Yoichi Otomi und 6 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
To evaluate global and regional myocardial 18 F-FDG uptake before and after thoracic radiotherapy (RT) for esophageal cancer under standardized fasting conditions, and to compare metabolic changes between heart-exposed and heart-spared patients. Patients and Methods: Sixty-three patients underwent paired pre-RT and post-RT FDG PET/CT following at least 12 hours of fasting. Patients were classified as heart-exposed (n = 47) or heart-spared (n = 16) based on RT treatment-field documentation. Cases with visually diffuse physiological myocardial uptake were excluded, yielding 30 nondiffuse cases (heart-exposed, n = 20; heart-spared, n = 10). Left ventricular (LV) SUVmax and regional SUVmean were analyzed using paired tests, and ΔSUVmax was compared between groups using the Mann–Whitney U test.
Results
In the entire cohort (n = 63), LV SUVmax increased from 7.0 ± 5.4 pre-RT to 8.3 ± 6.3 post-RT without statistical significance ( P = 0.114). In nondiffuse cases, LV SUVmax increased significantly from 3.5 ± 1.1 to 4.5 ± 2.4 ( P = 0.016). Among heart-exposed nondiffuse patients, SUVmax increased significantly (3.4 ± 1.3–4.9 ± 2.8; P = 0.019), whereas no significant change was observed in heart-spared patients (3.5±0.8–3.7±0.9; P = 0.557). Regional analysis demonstrated a significant post-radiotherapy increase in septal wall SUVmean in heart-exposed patients, with a similar increasing trend observed in the inferior wall.
Conclusions
FDG PET detects early, localized myocardial metabolic activation after thoracic RT in heart-exposed patients, whereas no significant change is observed in heart-spared patients, supporting its utility for early assessment of radiation-associated myocardial effects.
Zitieren
APA
Otomi, Y., Otsuka, H., Shinya, T., Arase, M., Yamaguchi, K., Goto, M., & Harada, M. (2026). Myocardial FDG Uptake Changes After Thoracic Radiotherapy With Cardiac Exposure. Clinical Nuclear Medicine Open, 3(2). https://doi.org/10.1097/nm9.0000000000000083
Vancouver
Otomi Y, Otsuka H, Shinya T, Arase M, Yamaguchi K, Goto M, et al. Myocardial FDG Uptake Changes After Thoracic Radiotherapy With Cardiac Exposure. Clinical Nuclear Medicine Open. 2026;3(2). doi:10.1097/nm9.0000000000000083
BibTeX
@article{Otomi2026,
author = {Otomi, Yoichi and Otsuka, Hideki and Shinya, Takayoshi and Arase, Maki and Yamaguchi, Koji and Goto, Masakazu and Harada, Masafumi},
title = {Myocardial FDG Uptake Changes After Thoracic Radiotherapy With Cardiac Exposure},
journal = {Clinical Nuclear Medicine Open},
year = {2026},
volume = {3},
number = {2},
doi = {10.1097/nm9.0000000000000083}
}
EUVIMED